In testimony before a House subcommittee, the Government Accountability Office identifies weaknesses in the Food & Drug Administration's foreign drug inspection program.
Alarmed by the recent heparin contamination originating from China, the House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, held a hearing yesterday on how the Food & Drug Administration can ensure drug safety. At the hearing, the Government Accountability Office
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.